Abstract
Tissue plasminogen activator (tPA) is the only recommended pharmacological treatment for acute ischemic stroke. However, tPA can induce intracerebral hemorrhage by blood–brain barrier breakdown through an increase in matrix metalloproteinases (MMPs). Previously, we showed that isoflurane postconditioning reduced intracranial hemorrhage following tPA treatment after cerebral ischemia. Here, we investigated the mechanism by which isoflurane postconditioning reduces tPA-induced MMP-2 and MMP-9 activation following hypoxia/reoxygenation (H/R) in brain endothelial cells. Mouse brain endothelial cells (bEnd.3) were exposed to 6 h of oxygen-glucose deprivation and 3 h of reoxygenation with tPA. Cells were treated with isoflurane for 1 h of the reoxygenation condition and the effect of isoflurane postconditioning on MMP-2 and MMP-9 activation was assessed. Involvement of low-density lipoprotein receptor-related protein (LRP), which is a receptor for tPA, and the extracellular signal-regulated kinase (ERK) and NF-κB pathway in isoflurane postconditioning was assessed using LRP inhibitor (receptor-associated protein, RAP) and ERK-1/2 inhibitor (PD98059). Isoflurane postconditioning decreased tPA-induced MMP-2 and MMP-9 activation under H/R. tPA treatment under H/R increased expression of LRP and the active form of NF-κB. Isoflurane postconditioning suppressed LRP expression, increased ERK-1/2 activation, and suppressed MMP-2 and MMP-9 activation, comparable to the effect of RAP. Activation of ERK-1/2, inhibition of NF-κB activation, and suppression of MMP-2 and MMP-9 activation by isoflurane postconditioning were abolished with PD98059 treatment. These finding indicate that isoflurane postconditioning inhibits tPA-induced MMP-2 and MMP-9 activation following H/R via the LRP/ERK/NF-κB pathway in bEnd.3.
Similar content being viewed by others
References
Jauch EC, Saver JL, Adams HP Jr et al (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44(3):870–947. doi:10.1161/STR.0b013e318284056a
Balami JS, Sutherland BA, Buchan AM (2013) Complications associated with recombinant tissue plasminogen activator therapy for acute ischaemic stroke. CNS Neurol Disord Drug Targets 12(2):155–169
Harston GW, Sutherland BA, Kennedy J, Buchan AM (2010) The contribution of l-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity. J Cereb Blood Flow Metab 30(11):1804–1816. doi:10.1038/jcbfm.2010.149
Lakhan SE, Kirchgessner A, Tepper D, Leonard A (2013) Matrix metalloproteinases and blood-brain barrier disruption in acute ischemic stroke. Front Neurol 4:32. doi:10.3389/fneur.2013.00032
Yang Y, Rosenberg GA (2011) Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke 42(11):3323–3328. doi:10.1161/strokeaha.110.608257
Kurzepa J, Kurzepa J, Golab P, Czerska S, Bielewicz J (2014) The significance of matrix metalloproteinase (MMP)-2 and MMP-9 in the ischemic stroke. Int J Neurosci 124(10):707–716. doi:10.3109/00207454.2013.872102
Lee S-R, Guo S-Z, Scannevin RH, Magliaro BC, Rhodes KJ, Wang X, Lo EH (2007) Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators. Neurosci Lett 417(1):1–5. doi:10.1016/j.neulet.2007.01.017
Suna X, Suna J, Liub L, Dinga Z (2013) Isoflurane preconditioning and postconditioning in multiple organs protection. J Biochem Pharmacol Res 1(1):6–14
Yu Q, Wang H, Chen J, Gao Y, Liang W (2010) Neuroprotections and mechanisms of inhalational anesthetics against brain ischemia. Front Biosci 2:1275–1298
Wang S, Yin J, Ge M, Dai Z, Li Y, Si J, Ma K, Li L, Yao S (2016) Transforming growth-beta 1 contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury by regulating the c-Jun N-terminal kinase signaling pathway. Biomed Pharmacother 78:280–290. doi:10.1016/j.biopha.2016.01.030
Zhao P, Ji G, Xue H, Yu W, Zhao X, Ding M, Yang Y, Zuo Z (2014) Isoflurane postconditioning improved long-term neurological outcome possibly via inhibiting the mitochondrial permeability transition pore in neonatal rats after brain hypoxia-ischemia. Neuroscience 280:193–203. doi:10.1016/j.neuroscience.2014.09.006
Li H, Yin J, Li L, Deng J, Feng C, Zuo Z (2013) Isoflurane postconditioning reduces ischemia-induced nuclear factor-kappaB activation and interleukin 1beta production to provide neuroprotection in rats and mice. Neurobiol Dis 54:216–224. doi:10.1016/j.nbd.2012.12.014
Lin D, Li G, Zuo Z (2011) Volatile anesthetic post-treatment induces protection via inhibition of glycogen synthase kinase 3beta in human neuron-like cells. Neuroscience 179:73–79. doi:10.1016/j.neuroscience.2011.01.055
Zhou Y, Lekic T, Fathali N, Ostrowski RP, Martin RD, Tang J, Zhang JH (2010) Isoflurane posttreatment reduces neonatal hypoxic-ischemic brain injury in rats by the sphingosine-1-phosphate/phosphatidylinositol-3-kinase/Akt pathway. Stroke 41(7):1521–1527. doi:10.1161/STROKEAHA.110.583757
Kim EJ, Kim SY, Lee JH, Kim JM, Kim JS, Byun JI, Koo BN (2015) Effect of isoflurane post-treatment on tPA-exaggerated brain injury in a rat ischemic stroke model. Korean J Anesthesiol 68(3):281–286. doi:10.4097/kjae.2015.68.3.281
May P, Woldt E, Matz RL, Boucher P (2007) The LDL receptor-related protein (LRP) family: an old family of proteins with new physiological functions. Ann Med 39(3):219–228. doi:10.1080/07853890701214881
Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA (2003) Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 112(10):1533–1540. doi:10.1172/JCI19212
Lu Z, Xu S (2006) ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life 58(11):621–631. doi:10.1080/15216540600957438
Gray JJ, Bickler PE, Fahlman CS, Zhan X, Schuyler JA (2005) Isoflurane neuroprotection in hypoxic hippocampal slice cultures involves increases in intracellular Ca2+ and mitogen-activated protein kinases. Anesthesiology 102(3):606–615
Bickler PE, Zhan X, Fahlman CS (2005) Isoflurane preconditions hippocampal neurons against oxygen-glucose deprivation: role of intracellular Ca2+ and mitogen-activated protein kinase signaling. Anesthesiology 103(3):532–539
Li QF, Zhu YS, Jiang H (2008) Isoflurane preconditioning activates HIF-1alpha, iNOS and Erk1/2 and protects against oxygen-glucose deprivation neuronal injury. Brain Res 1245:26–35. doi:10.1016/j.brainres.2008.09.069
Li G, Jia J, Fu J, Wang H, Ji K, Zang B (2014) [The effects of preconditioning and postconditioning with isoflurane on focal cerebral ischemi/reperfusion injury in rats]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 26 (6):431–435. doi:10.3760/cma.j.issn.2095-4352.2014.06.013
Kudo M, Aono M, Lee Y, Massey G, Pearlstein RD, Warner DS (2001) Absence of direct antioxidant effects from volatile anesthetics in primary mixed neuronal-glial cultures. Anesthesiology 94(2):303–312
Won S, Lee JH, Wali B, Stein DG, Sayeed I (2014) Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway. J Cereb Blood Flow Metab 34(1):72–80. doi:10.1038/jcbfm.2013.163
Huang Z, Lee H, Lee E, Kang SK, Nam JM, Lee M (2011) Responsive nematic gels from the self-assembly of aqueous nanofibres. Nat Commun 2:459. doi:10.1038/ncomms1465
Collen A, Hanemaaijer R, Lupu F, Quax PH, van Lent N, Grimbergen J, Peters E, Koolwijk P, van Hinsbergh VW (2003) Membrane-type matrix metalloproteinase-mediated angiogenesis in a fibrin-collagen matrix. Blood 101(5):1810–1817. doi:10.1182/blood-2002-05-1593
Godfrey KR, Tanswell P, Bates RA, Chappell MJ, Madden FN (1998) Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species: a comparison of mathematical models. Biopharm Drug Dispos 19(2):131–140
Won S, Lee JK, Stein DG (2015) Recombinant tissue plasminogen activator promotes, and progesterone attenuates, microglia/macrophage M1 polarization and recruitment of microglia after MCAO stroke in rats. Brain Behav Immun 49:267–279. doi:10.1016/j.bbi.2015.06.007
Wang XY, Lee SR, Arai K, Lee SR, Tsuji K, Rebeck GW, Lo EH (2003) Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med 9(10):1313–1317. doi:10.1038/nm926
Golab P, Kielbus M, Bielewicz J, Kurzepa J (2015) The effect of recombinant tissue plasminogen activator on MMP-2 and MMP-9 activities in vitro. Neurol Res 37(1):9–13. doi:10.1179/1743132814Y.0000000412
Rha JH, Saver JL (2007) The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke 38(3):967–973. doi:10.1161/01.str.0000258112.14918.24
Suzuki Y, Nagai N, Yamakawa K, Kawakami J, Lijnen HR, Umemura K (2009) Tissue-type plasminogen activator (t-PA) induces stromelysin-1 (MMP-3) in endothelial cells through activation of lipoprotein receptor-related protein. Blood 114(15):3352–3358. doi:10.1182/blood-2009-02-203919
Zhang C, An J, Haile WB, Echeverry R, Strickland DK, Yepes M (2009) Microglial low-density lipoprotein receptor-related protein 1 mediates the effect of tissue-type plasminogen activator on matrix metalloproteinase-9 activity in the ischemic brain. J Cereb Blood Flow Metab 29(12):1946–1954. doi:10.1038/jcbfm.2009.174
Hu K, Yang J, Tanaka S, Gonias SL, Mars WM, Liu Y (2006) Tissue-type plasminogen activator acts as a cytokine that triggers intracellular signal transduction and induces matrix metalloproteinase-9 gene expression. J Biol Chem 281(4):2120–2127. doi:10.1074/jbc.M504988200
Adya R, Tan BK, Chen J, Randeva HS (2008) Nuclear factor-kappaB induction by visfatin in human vascular endothelial cells: its role in MMP-2/9 production and activation. Diabetes Care 31(4):758–760. doi:10.2337/dc07-1544
Kovalska M, Kovalska L, Pavlikova M, Janickova M, Mikuskova K, Adamkov M, Kaplan P, Tatarkova Z, Lehotsky J (2012) Intracellular signaling MAPK pathway after cerebral ischemia-reperfusion injury. Neurochem Res 37(7):1568–1577. doi:10.1007/s11064-012-0752-y
Kovalska M, Kovalska L, Mikuskova K, Adamkov M, Tatarkova Z, Lehotsky J (2014) p-ERK involvement in the neuroprotection exerted by ischemic preconditioning in rat hippocampus subjected to four vessel occlusion. J Physiol Pharmacol 65(6):767–776
Zhang QG, Wang RM, Han D, Yang LC, Li J, Brann DW (2009) Preconditioning neuroprotection in global cerebral ischemia involves NMDA receptor-mediated ERK-JNK3 crosstalk. Neurosci Res 63(3):205–212
Franks NP, Lieb WR (1996) Temperature dependence of the potency of volatile general anesthetics: implications for in vitro experiments. Anesthesiology 84(3):716–720
Rahman NA, Rasil AN, Meyding-Lamade U, Craemer EM, Diah S, Tuah AA, Muharram SH (2016) Immortalized endothelial cell lines for in vitro blood-brain barrier models: a systematic review. Brain Res 1642:532–545. doi:10.1016/j.brainres.2016.04.024
Acknowledgements
This study was financially supported by the “Dongwha Holdings” Faculty Research Assistance Program of Yonsei University College of Medicine for 6-2014-0058 to So Yeon Kim, the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No. 2014R1A2A2A01007289) to Bon-Nyeo Koo.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to disclose.
Rights and permissions
About this article
Cite this article
Kim, S.Y., Cheon, S.Y., Kim, E.J. et al. Isoflurane Postconditioning Inhibits tPA-Induced Matrix Metalloproteinases Activation After Hypoxic Injury via Low-Density Lipoprotein Receptor-Related Protein and Extracellular Signal-Regulated Kinase Pathway. Neurochem Res 42, 1533–1542 (2017). https://doi.org/10.1007/s11064-017-2211-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-017-2211-2